Who owns MARAVAI LIFESCIENCES HOLDINGS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MRVI from SEC Form 13F filings across 202 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 202 institutions disclosed 145.3M shares of MARAVAI LIFESCIENCES HOLDINGS, INC. worth $1.11B — about 97.5% of shares outstanding; the largest disclosed holder is GTCR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
202
13F holders
$1.11B
value, 2026 filers
97.5%
of shares outstanding (145.3M sh)
53
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MRVI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GTCR LLC | 20.2M | $154.3M | 3.6% | 13.5% | 0.0% |
| 2 | BlackRock, Inc. | 10.6M | $80.9M | 0.0% | 7.1% | +5.9% |
| 3 | MILLENNIUM MANAGEMENT LLC | 7.6M | $58.4M | 0.0% | 5.1% | +17.1% |
| 4 | FMR LLC | 6.9M | $52.9M | 0.0% | 4.6% | +20116.3% |
| 5 | AMERIPRISE FINANCIAL INC | 5.8M | $44.7M | 0.0% | 3.9% | +2678.3% |
| 6 | BRAIDWELL LP | 5.5M | $42.2M | 1.7% | 3.7% | -36.8% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 5.3M | $40.2M | 0.0% | 3.5% | -0.6% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 4.0M | $30.5M | 0.0% | 2.7% | -13.4% |
| 9 | 12 West Capital Management LP | 3.8M | $29.1M | 5.5% | 2.5% | -46.2% |
| 10 | WELLINGTON MANAGEMENT GROUP LLPNEW | 3.7M | $28.1M | 0.0% | 2.5% | new |
| 11 | Nuveen, LLC | 3.5M | $26.7M | 0.0% | 2.3% | +22.2% |
| 12 | First Eagle Investment Management, LLC | 3.3M | $25.1M | 0.0% | 2.2% | -10.6% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 3.1M | $23.9M | 0.0% | 2.1% | -0.4% |
| 14 | STATE STREET CORP | 3.1M | $23.4M | 0.0% | 2.1% | +5.3% |
| 15 | Qube Research & Technologies Ltd | 2.9M | $22.3M | 0.0% | 2% | +288.9% |
| 16 | MORGAN STANLEY | 2.7M | $20.8M | 0.0% | 1.8% | +42.1% |
| 17 | Point72 Asset Management, L.P. | 2.5M | $19.3M | 0.0% | 1.7% | +25.4% |
| 18 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.5M | $19.1M | 0.0% | 1.7% | +64.5% |
| 19 | TWO SIGMA INVESTMENTS, LP | 2.2M | $16.8M | 0.0% | 1.5% | -2.6% |
| 20 | GOLDMAN SACHS GROUP INC | 2.0M | $15.7M | 0.0% | 1.4% | +24.5% |
| 21 | MARSHALL WACE, LLP | 2.0M | $15.6M | 0.0% | 1.4% | +38.2% |
| 22 | CITADEL ADVISORS LLC | 1.9M | $14.2M | 0.0% | 1.2% | -12.5% |
| 23 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 1.8M | $14.1M | 0.3% | 1.2% | +10.4% |
| 24 | GENERAL AMERICAN INVESTORS CO INC | 1.7M | $13.1M | 0.8% | 1.2% | 0.0% |
| 25 | ROYCE & ASSOCIATES LP | 1.7M | $13.1M | 0.1% | 1.1% | -5.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.